Whether Tepotinib has been included in medical insurance and the reimbursement ratio

Tepotinib (Tepotinib), as a targeted drug targeting MET exon 14 skipping mutations, has been officially launched in China and has been included in the medical insurance system. This means that patients who meet the indications can reimburse part of the cost through medical insurance when purchasing it in the hospital, thus reducing the financial pressure on medication. However, the specific reimbursement ratio and self-payment amount will vary depending on regional policies and medical insurance types. Therefore, patients should consult the local hospital pharmacy or medical insurance department for detailed reimbursement policies before purchasing drugs.

In the domestic market, the original drug price of tepotinib is relatively high, with one box costing about more than 30,000 yuan. Although patients can receive a certain percentage of reimbursement after being included in medical insurance, the self-pay part may still cause certain financial pressure on some families. Clinically, doctors will rationally arrange medication plans based on the patient's condition and financial situation, combined with medical insurance reimbursement policies, to ensure continuity and safety of treatment.

In contrast, in overseas markets, the price of generic drugs of tepotinib is more affordable. In the Laotian market, the price of Tepotinib generic drugs produced by Lucius and Daxiong has been significantly reduced recently. Each box costs about more than 6,000 yuan, and its drug ingredients are basically the same as the domestic original drugs. Overseas generic drugs provide viable alternatives for patients with limited economic conditions, but they need to be purchased through formal channels to ensure drug quality and safety.

Generally speaking, tepotinib has been included in medical insurance in China, and patients can enjoy part of the reimbursement policy, but they still need to pay attention to the out-of-pocket part and regional differences. At the same time, the low prices of overseas generic drugs provide patients with additional medication options. When choosing a drug purchase channel, patients should comprehensively consider medical insurance reimbursement, drug availability, and doctor's advice to ensure treatment safety and maximum efficacy.

Reference materials:https://www.drugs.com/